EVOK Evoke Pharma
- 5.0700
- -0.4200-7.65%
- 5.0700
- 0.00000.00%
Evoke Pharma News
Evoke Pharma Highlights GIMOTI As A Leading Solution For Gastroparesis Treatment As Domperidone Supply Ends; FDA Posts Update As Mechanism To Obtain Unapproved Domperidone Expected To Lose Supply In Early 2025
Express News | Evoke Pharma Inc: Two Patents Are Expected to Be Orange Book Listable and Expire at End of 2029
Express News | Evoke Pharma Receives Notices of Allowance for Two Additional US Patent Applications Protecting Gimoti®
US Manufacturing Index Rises To 43, Highest Since 2020
Evoke Pharma GAAP EPS of -$0.94, Revenue of $2.65M
Evoke Pharma | 8-K: Evoke Pharma, Inc. Reports Third Quarter 2024 Financial Results
Evoke Pharma | 10-Q: Q3 2024 Earnings Report
Express News | Evoke Pharma, Inc. Reports Third Quarter 2024 Financial Results
Evoke Pharma 3Q Loss/Shr 94c >EVOK
Press Release: Evoke Pharma, Inc. Reports Third Quarter 2024 Financial Results
Why VF Corp Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket
Crude Oil Tumbles Over 5%; Autonomix Medical Shares Spike Higher
Evoke Stock Rockets 90% on Study of Gimoti in GLP-1 Users
Dow Jumps Over 300 Points; ON Semiconductor Earnings Top Views
Evoke Pharma Shares Resume Trade
Evoke Pharma Stock Is Soaring Monday: What's Going On?
12 Health Care Stocks Moving In Monday's Pre-Market Session
Evoke Pharma Says Study Showed Gimoti Reduces Emergency Visits in Diabetic Gastroparesis Patients Using GLP-1; Shares Surge Pre-Bell
Top Premarket Gainers
Express News | Evoke Pharma Shares More Than Triple Premarket After Study Shows Potential of Co's Nasal Spray as Supportive Care for GLP-1 Therapy
No Data